Nonalcoholic fatty liver disease and metabolic syndrome: a concise review.
Non-alcoholic fatty liver disease (NAFLD) is a clinicopathological entity increasingly recognized as a major health burden in developed countries. In the last decade, several studies have independently provided evidence for a strong association between NAFLD and each component of the metabolic syndrome, including central obesity, hyperglycemia, dyslipidemia, and hypertension. This article focuses on epidemiological, clinical, pathogenic and therapeutic aspects, which link these two syndromes.
Streba
Letiţia Adela Maria
LA
Department of Internal Medicine 1, Filantropia University Hospital of Craiova, University of Medicine and Pharmacy of Craiova, Romania. letitiastreba@yahoo.com
Cârstea
Doina
D
Mitruţ
P
P
Vere
C C
CC
Dragomir
Nicoleta
N
Streba
C T
CT
D000273:Adipose Tissue / Q000502:physiology; D003210:Concept Formation; D005234:Fatty Liver / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D006801:Humans; D007333:Insulin Resistance / Q000502:physiology; D024821:Metabolic Syndrome / Q000175:diagnosis / Q000209:etiology*; D018384:Oxidative Stress / Q000502:physiology